Effect of eptifibatide on platelet-mediated inflammation in acute coronary syndromes.
administration of the combination perindopril/indapamide was associated with a consistent reduction of CV mortality in diabetic patients [11]. Our hypothesis may be verified by post-monitoring follow-up of large trials investigating effects of RAAS blockade compared with other anti-hypertensive classes in diabetic patients. The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology (Shewan and Coats 2010;144:1–2).